ANGPTL8 and fatty liver disease: Of note, the treatment with Angptl8 anti-sense oligonucleotides markedly alleviated HFD-induced hepatic steatosis in rodents [148], presumably due to ANGPTL8 promoting lipogenesis via upregulating nuclear sterol-regulatory element binding protein 1 (SREBP1) [149].